EPEvelyn P. Parsons

Evelyn P. Parsons

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Evelyn P. Parsons has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • A J Clarke

    Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, Wales, UK

    2 shared publications
  • D M Bradley

    Department of Medical Biochemistry, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, Wales, UK

    2 shared publications
  • E Lycett

    Family and Child Psychology Research Centre, City University, London, UK

    1 shared publication
  • Emma J Lycett

    Research Officer, School of Nursing Studies, UWCM, Cardiff, UK

    1 shared publication
  • Helen Bennett

    School of Nursing Studies, UWCM, Cardiff, UK

    1 shared publication
  • Jo Jones

    School of Nursing Studies, UWCM, Cardiff, UK

    1 shared publication

Latest Publications

  • Implications of carrier identification in newborn screening for cystic fibrosis: Table 1

    by E P Parsons, A J Clarke, D M Bradley

    Objective: To investigate the psychosocial implications for families whose infant was identified as a cystic fibrosis carrier by newborn screening. Design: Prospective psychosocial assessment. Setting: Primary care. Respondents: Study: (a) families of an affected infant identified by screening (n = 9); (b) families of a carrier infant identified by screening (n = 10). Control: group of mothers from the general population (n = 82). Interventions: Questionnaires and semistructured interviews. Main outcome measures: Attitude to screening, assessments of the mother/baby relationship, anxiety, wellbeing. Results: All families were in favour of screening, with no evidence that the mother/baby relationship, anxiety or wellbeing had been adversely affected. Parents, however, did identify problems in terms of the service delivery protocol and genetic counselling practice. Conclusion: Six months after disclosure, carrier identification was not perceived by parents to be problematic.


  • Open Access

    Newborn screening for Duchenne muscular dystrophy: a psychosocial study

    by E P Parsons, A J Clarke, K Hood, E Lycett, D M Bradley

    Objective: To evaluate the psychosocial implications of newborn screening for Duchenne muscular dystrophy. Design: Prospective psychosocial assessment. Setting: Primary care. Respondents: Study: (a) families of an affected boy identified by screening (n = 20); (b) families of a boy with a transient screening abnormality (n = 18). Control: (a) families of a boy with a later clinical diagnosis (n = 16); (b) random sample of mothers of boys aged 6–9 months (n = 43). Interventions: Questionnaires and semistructured interviews. Main outcome measures: Attitudes to newborn screening and impact of screening on mother-baby relationship, anxiety/wellbeing, and reproductive patterning within families of an affected boy. Results: Most families of an affected boy were in favour of newborn screening on the grounds of reproductive choice and time to prepare emotionally and practically. There was no evidence of any long term disruption to the mother-baby relationship. Anxiety levels for the screened group were slightly above threshold but returned to normal during the period of the study. There was no evidence, from anxiety or wellbeing scores, that the transient group had suffered any disadvantage. Although the profile of the screened and later clinically diagnosed cohorts was similar after diagnosis, when boys from the screened cohort were 4 years old and more socially aware, their profile was more positive. There was evidence that reproductive patterning had been modified, and four fetuses carrying a mutation causing Duchenne muscular dystrophy were terminated. Conclusion: A case can be made for newborn screening provided that the test is optional, a rigorous protocol for service delivery is used, and an infrastructure providing continuing support is in place.


  • Open Access

    Reassurance through surveillance in the face of clinical uncertainty: the experience of women at risk of familial breast cancer

    by Evelyn P. Parsons, Valerie Beale, Helen Bennett, Jo Jones, Emma J Lycett

    To identify the main issues raised by clinicians when they are counselling women at risk of breast cancer and explore the response of a group of women 1 year after counselling. A qualitative study which involved the thematic analysis of a series of transcripts from clinical consultations, semi-structured interviews and focus groups. First, a series of clinical consultations (n=153), involving seven clinicians, were randomly selected during a Medical Research Council funded study of genetic assessment (TRACE). Second, a group of women (n=43), involved in the TRACE study, were interviewed, or joined a focus group, 1 year after their genetic assessment. There was evidence that, although the clinical consultations were embedded with multiple messages of uncertainty, the women’s accounts did not reflect this. The women talked about the reassurance they had found because they had met with an expert and become members of the surveillance society. The authors highlight the tension that exists because of the difference between lay expectations about on-going surveillance and the realities of collective service provision.